GO ID Molecular Function | GO Term | No. Genes | P | Fold Enrichment |
---|---|---|---|---|
GO:0005515 | protein binding | 352 | 0.004 | 1.09 |
GO:0016853 | isomerase activity | 19 | 0.007 | 1.85 |
GO:0005200 | structural constituent of cytoskeleton | 7 | 0.026 | 2.72 |
GO:0003700 | transcription factor activity | 39 | 0.031 | 1.36 |
GO:0016860 | intramolecular oxidoreductase activity | 8 | 0.037 | 2.33 |
GO:0031072 | heat shock protein binding | 9 | 0.078 | 1.91 |
GO:0051082 | unfolded protein binding | 16 | 0.096 | 1.49 |
Cellular Compartment | Â | Â | Â | Â |
GO:0044428 | nuclear part | 83 | 0.009 | 1.27 |
GO:0044446 | intracellular organelle part | 194 | 0.015 | 1.13 |
GO:0044422 | organelle part | 195 | 0.016 | 1.13 |
GO:0031974 | membrane-enclosed lumen | 75 | 0.018 | 1.26 |
GO:0043233 | organelle lumen | 75 | 0.018 | 1.26 |
GO:0005667 | transcription factor complex | 19 | 0.024 | 1.67 |
GO:0015629 | actin cytoskeleton | 15 | 0.029 | 1.78 |
GO:0044451 | nucleoplasm part | 37 | 0.032 | 1.37 |
GO:0005886 | plasma membrane | 79 | 0.042 | 1.20 |
GO:0016020 | membrane | 222 | 0.049 | 1.09 |
GO:0005654 | nucleoplasm | 40 | 0.061 | 1.29 |
GO:0031981 | nuclear lumen | 51 | 0.064 | 1.24 |
GO:0001725 | stress fiber | 4 | 0.066 | 3.79 |
GO:0032432 | actin filament bundle | 4 | 0.066 | 3.79 |
GO:0030864 | cortical actin cytoskeleton | 4 | 0.066 | 3.79 |
GO:0030863 | cortical cytoskeleton | 5 | 0.066 | 2.96 |
GO:0030054 | cell junction | 15 | 0.074 | 1.58 |
GO:0044433 | cytoplasmic vesicle part | 10 | 0.077 | 1.82 |
GO:0030659 | cytoplasmic vesicle membrane | 10 | 0.077 | 1.82 |
GO:0044448 | cell cortex part | 6 | 0.087 | 2.37 |
GO:0031410 | cytoplasmic vesicle | 28 | 0.090 | 1.33 |
GO:0012506 | vesicle membrane | 10 | 0.095 | 1.75 |
GO:0016023 | cytoplasmic membrane-bound vesicle | 24 | 0.098 | 1.35 |
GO:0005770 | late endosome | 7 | 0.100 | 2.07 |
Biological Process | Â | Â | Â | Â |
GO:0051640 | organelle localization | 5 | 0.021 | 3.92 |
GO:0006457 | protein folding | 29 | 0.029 | 1.45 |
GO:0051650 | establishment of vesicle localization | 4 | 0.032 | 4.70 |
GO:0051648 | vesicle localization | 4 | 0.032 | 4.70 |
GO:0006903 | vesicle targeting | 4 | 0.032 | 4.70 |
GO:0050790 | regulation of catalytic activity | 26 | 0.044 | 1.44 |
GO:0051726 | regulation of cell cycle | 34 | 0.045 | 1.36 |
GO:0000074 | regulation of progression through cell cycle | 34 | 0.045 | 1.36 |
GO:0048523 | negative regulation of cellular process | 64 | 0.050 | 1.22 |
GO:0016568 | chromatin modification | 19 | 0.058 | 1.51 |
GO:0051656 | establishment of organelle localization | 4 | 0.067 | 3.76 |
GO:0065009 | regulation of a molecular function | 29 | 0.076 | 1.34 |
GO:0048519 | negative regulation of biological process | 65 | 0.080 | 1.19 |
GO:0007049 | cell cycle | 49 | 0.080 | 1.23 |
GO:0031324 | negative regulation of cellular metabolic process | 25 | 0.082 | 1.37 |
KEGG ID | Â | Â | Â | Â |
hsa04010 | MAPK signaling pathway | 13 | 0.060 | 1.69 |
hsa04510 | Focal adhesion | 17 | 0.099 | 1.45 |
hsa04115 | p53 signaling pathway | 5 | 0.163 | 2.24 |
hsa00590 | Arachidonic acid metabolism | 3 | 0.182 | 3.70 |
hsa04910 | Insulin signaling pathway | 9 | 0.183 | 1.59 |
hsa05211 | Renal cell carcinoma | 7 | 0.198 | 1.73 |
hsa04670 | Leukocyte transendothelial migration | 7 | 0.233 | 1.64 |
hsa04150 | mTOR signaling pathway | 4 | 0.265 | 2.19 |
hsa00720 | Reductive carboxylate cycle (CO2 fixation) | 3 | 0.265 | 2.96 |
hsa04930 | Type II diabetes mellitus | 3 | 0.265 | 2.96 |